We are live on ! Find out more
PHIC

Pine Haven Investment Counsel Portfolio holdings

AUM $149M
1-Year Est. Return 23.2%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+23.2%
3 Year Est. Return
+72.08%
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
+$8.13M
Cap. Flow
-$502K
Cap. Flow %
-0.39%
Top 10 Hldgs %
41.78%
Holding
116
New
3
Increased
39
Reduced
36
Closed
5

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$254K
2
SAM icon
Boston Beer
SAM
+$214K
3
CVX icon
Chevron
CVX
+$213K
4
CTSH icon
Cognizant
CTSH
+$212K
5
VZ icon
Verizon
VZ
+$211K

Sector Composition

Rank Sector Weight
1 Technology 26.86%
2 Healthcare 11.88%
3 Financials 10.56%
4 Consumer Staples 9.48%
5 Consumer Discretionary 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
76
Norfolk Southern
NSC
$75B
$352K 0.28%
1,376
ROP icon
77
Roper Technologies
ROP
$39.9B
$349K 0.27%
615
APD icon
78
Air Products & Chemicals
APD
$68.6B
$339K 0.27%
1,202
MMM icon
79
3M
MMM
$93.9B
$339K 0.27%
2,225
-125
-5% -$17.9K
IBDQ
80
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$327K 0.26%
13,000
+300
+2% +$7.54K
VCSH icon
81
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.9B
$319K 0.25%
4,014
-146
-4% -$11.5K
LLY icon
82
Eli Lilly
LLY
$1.1T
$316K 0.25%
406
+6
+2% +$4.66K
CVS icon
83
CVS Health
CVS
$122B
$311K 0.24%
4,512
-1,383
-23% -$90.7K
PAYX icon
84
Paychex
PAYX
$43.1B
$307K 0.24%
2,109
-156
-7% -$23.5K
EXPD icon
85
Expeditors International
EXPD
$23.3B
$294K 0.23%
2,570
IBDR icon
86
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
$293K 0.23%
12,100
+500
+4% +$12.1K
XLF icon
87
State Street Financial Select Sector SPDR ETF
XLF
$59B
$292K 0.23%
5,570
IBDS icon
88
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.86B
$283K 0.22%
11,650
+950
+9% +$22.9K
DKS icon
89
Dick's Sporting Goods
DKS
$19.2B
$282K 0.22%
1,424
+145
+11% +$26.9K
FDS icon
90
Factset
FDS
$10.1B
$275K 0.22%
615
AFL icon
91
Aflac
AFL
$61.2B
$273K 0.21%
2,590
-250
-9% -$26.3K
NTES icon
92
NetEase
NTES
$85.4B
$269K 0.21%
2,000
TRI icon
93
Thomson Reuters
TRI
$45.2B
$262K 0.21%
1,282
TXN icon
94
Texas Instruments
TXN
$256B
$259K 0.2%
1,246
+14
+1% +$2.48K
MDYG icon
95
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.93B
$258K 0.2%
+2,975
New +$243K
PM icon
96
Philip Morris
PM
$290B
$255K 0.2%
1,400
SO icon
97
Southern Company
SO
$105B
$255K 0.2%
2,773
SCHE icon
98
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$251K 0.2%
8,322
-300
-3% -$8.49K
HON icon
99
Honeywell
HON
$77B
$241K 0.19%
1,098
INTU icon
100
Intuit
INTU
$91.5B
$240K 0.19%
+305
New +$206K

Similar funds

Pine Haven Investment Counsel's Q2 2025 Portfolio in Review

As of Q2 2025, Pine Haven Investment Counsel held 116 positions worth $127M, up 6.8% from $119M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Pine Haven Investment Counsel's Q2 2025 filing shows 3 new, 39 increased, 36 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Growth ETF: 2,975 shares worth $258K. The largest sale was Bristol-Myers Squibb, an estimated $254K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Pine Haven Investment Counsel's largest Q2 2025 buy was State Street SPDR S&P 400 Mid Cap Growth ETF: 2,975 shares worth $258K.
  • Pine Haven Investment Counsel added most to iShares ESG Aware US Aggregate Bond ETF in Q2 2025, an estimated $173K increase.
  • Pine Haven Investment Counsel's biggest Q2 2025 reduction was CVS Health, cutting an estimated $90.7K.
  • Pine Haven Investment Counsel fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $254K.
  • Pine Haven Investment Counsel's ten largest holdings make up 42% of its $127M portfolio in Q2 2025.
  • Pine Haven Investment Counsel opened 3 new positions and closed 5 in Q2 2025.
  • Pine Haven Investment Counsel's portfolio value rose 6.8% quarter-over-quarter to $127M.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2025, filed 15 Jul 2025.